UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206

Annals of oncology, 2018-01, Vol.29 (1), p.209-214

2018

Volltextzugriff (PDF)

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

Annals of oncology, 2015-05, Vol.26 (5), p.894-901

2015

Volltextzugriff (PDF)

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

Annals of oncology, 2018-02, Vol.29 (2), p.341-346

2018

Volltextzugriff (PDF)

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014

Annals of oncology, 2016-05, Vol.27 (5), p.875-879

2016

Volltextzugriff (PDF)

Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial

Annals of oncology, 2017-07, Vol.28 (7), p.1419-1426

2017

Volltextzugriff (PDF)

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial

Lung cancer (Amsterdam, Netherlands), 2006-04, Vol.52 (1), p.93-97

2006

Volltextzugriff (PDF)

Survival of Patients with Stage I Lung Cancer Detected on CT Screening

Year book of medicine, 2008-01, Vol.2008, p.175-177

Hanna, N.H.

2008

Volltextzugriff (PDF)

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

The Year book of oncology, 2008-01, Vol.2008, p.219-221

Hanna, N.H.

2008

Volltextzugriff (PDF)

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

The Year book of oncology, 2008-01, Vol.2008, p.181-183

Hanna, N.H.

2008

Volltextzugriff (PDF)

Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

The Year book of oncology, 2008-01, Vol.2008, p.180-181

Hanna, N.H.

2008

Volltextzugriff (PDF)

RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.164-165

Hanna, N.H.

2008

Volltextzugriff (PDF)

Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.176-178

Hanna, N.H.

2008

Volltextzugriff (PDF)

Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.183-184

Hanna, N.H.

2008

Volltextzugriff (PDF)

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.357-360

Hanna, N.H.

2008

Volltextzugriff (PDF)

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

Year book of medicine, 2008-01, Vol.2008, p.184-187

Hanna, N.H.

2008

Volltextzugriff (PDF)

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

The Year book of oncology, 2008-01, Vol.2008, p.188-189

Hanna, N.H.

2008

Volltextzugriff (PDF)

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

Year book of medicine, 2008-01, Vol.2008, p.187-189

Hanna, N.H.

2008

Volltextzugriff (PDF)

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

Year book of medicine, 2008-01, Vol.2008, p.182-184

Hanna, N.H.

2008

Volltextzugriff (PDF)

Respiratory Symptoms, Pulmonary Function, and Markers of Inflammation Among Bar Workers Before and After a Legislative Ban on Smoking in Public Places

Year book of medicine, 2008-01, Vol.2008, p.173-175

Hanna, N.H.

2008

Volltextzugriff (PDF)

Survival of Patients with Stage I Lung Cancer Detected on CT Screening

The Year book of oncology, 2008-01, Vol.2008, p.149-151

Hanna, N.H.

2008

Volltextzugriff (PDF)

Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non–Small-Cell Lung Cancer—A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group

The Year book of oncology, 2008-01, Vol.2008, p.163-164

Hanna, N.H.

2008

Volltextzugriff (PDF)

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.156-158

Hanna, N.H.

2008

Volltextzugriff (PDF)

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.196-198

Hanna, N.H.

2008

Volltextzugriff (PDF)

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.178-179

Hanna, N.H.

2008

Volltextzugriff (PDF)

Phase II Clinical Trial of Chemotherapy-Naïve Patients≥70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

The Year book of oncology, 2008-01, Vol.2008, p.185-186

Hanna, N.H.

2008

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(13)

Publikationsform

Sprache

Englisch
(154)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Humans
(9)
Male
(9)
Life Sciences & Biomedicine
(8)
Middle Aged
(8)
Adult
(6)
Female
(6)
Oncology
(6)
Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Lung Neoplasms - Drug Therapy
(4)
Time Factors
(4)
Biological And Medical Sciences
(3)
Disease-Free Survival
(3)
Germ-Cell Tumor
(3)
Medical Sciences
(3)
Original
(3)
Retrospective Studies
(3)
Survival Rate
(3)
Treatment Outcome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014

Statistical controversies in clinical research: futility analyses in oncology–lessons on potential pitfalls from a randomized controlled trial

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: A Hoosier Oncology Group phase II trial

Survival of Patients with Stage I Lung Cancer Detected on CT Screening

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

Phase II Trial of Amrubicin for Treatment of Refractory or Relapsed Small-Cell Lung Cancer: Thoracic Oncology Research Group Study 0301

RRM1 Modulated In Vitro and In Vivo Efficacy of Gemcitabine and Platinum in Non–Small-Cell Lung Cancer

Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer

Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

Respiratory Symptoms, Pulmonary Function, and Markers of Inflammation Among Bar Workers Before and After a Legislative Ban on Smoking in Public Places

Survival of Patients with Stage I Lung Cancer Detected on CT Screening

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Phase II Clinical Trial of Chemotherapy-Naïve Patients≥70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

Suchergebnisse filtern